維生素D結(jié)合蛋白(DBP)重組蛋白
Recombinant Vitamin D Binding Protein (DBP)
GC; VDBG; VDBP; Group-Specific Component; Gc-globulin
- 編號(hào)URPB810Mu03
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來(lái)源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位分泌
- 預(yù)測(cè)分子量81.9kDa
- 實(shí)際分子量82kDa(差異分析請(qǐng)參閱說(shuō)明書)
- 片段與標(biāo)簽Leu17~Ser476 with N-terminal His and GST Tag
- 緩沖液成份20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose .
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)5.7
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請(qǐng)參見(jiàn)活性蛋白。 - 下載 英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 516 ¥ 1290 ¥ 2580 ¥ 7740 ¥ 19350
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure. Gene Sequencing (Extract)
-
SDS-PAGE圖
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
Figure. SDS-PAGE
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UEPB810Mu62 | 維生素D結(jié)合蛋白(DBP)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPB810Mu61 | 維生素D結(jié)合蛋白(DBP)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB810Mu01 | 維生素D結(jié)合蛋白(DBP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB810Mu02 | 維生素D結(jié)合蛋白(DBP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB810Mu03 | 維生素D結(jié)合蛋白(DBP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB810Mu02 | 維生素D結(jié)合蛋白(DBP)多克隆抗體 | WB; IHC |
| UPAB810Mu01 | 維生素D結(jié)合蛋白(DBP)多克隆抗體 | WB; IHC |
| UPAB810Mu03 | 維生素D結(jié)合蛋白(DBP)多克隆抗體 | WB; IHC |
| UFAB810Mu01 | 抗維生素D結(jié)合蛋白(DBP)多克隆抗體 | FCM |
| ULAB810Mu71 | 維生素D結(jié)合蛋白(DBP)多克隆抗體(生物素標(biāo)記) | WB |
| USEB810Mu | 維生素D結(jié)合蛋白(DBP)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMB810Mu | 維生素D結(jié)合蛋白(DBP)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UPGB810Mu03 | 維生素D結(jié)合蛋白(DBP)引物對(duì) | PCR |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Proteome Science | Isotope Coded Protein Labeling analysis of plasma specimens from acute severe dengue fever patients [PubMed: 23101585] |
| Toxins (Basel). | Increased Circulating Levels of Vitamin D Binding Protein in MS Patients [Pubmed:25590278] |
| Endocrine | Vitamin D-binding protein and free vitamin D concentrations in acromegaly [PubMed: 26547217] |
| Proteomics Clinical Applications | Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients [Pubmed:26680509] |
| PLoS One. | 25-Hydroxivitamin D Serum Concentration, Not Free and Bioavailable Vitamin D, Is Associated with Disease Activity in Systemic Lupus Erythematosus Patients. [pubmed:28085957] |
| PROTEOMICS?-?Clinical?Applications | Comparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients. [pubmed:26680509] |
| Plos One | 25-Hydroxivitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients [10.1371/journal.pone.0170323] |
| Nutrients | Gene Expression of Sirtuin-1 and Endogenous Secretory Receptor for Advanced Glycation End Products in Healthy and Slightly Overweight Subjects after?… [Pubmed:30037068] |
| BBA- Molecular Basis of Disease | Enhanced remedial effects for vitamin D3 and calcium co-supplementation against pre-existing lead nephrotoxicity in mice: The roles of renal calcium homeostatic?… [Pubmed: 30553018] |
| J Clin Res Pediatr Endocrinol | Is Bioavailable Vitamin D Better Than Total Vitamin D to Evaluate Vitamin D Status in Obese Children? [34013709] |
| PLoS One | Leukocyte telomere length as a compensatory mechanism in vitamin D metabolism [Pubmed:35202418] |
留言咨詢
